Does an expertise in EEG, with its accompanying understanding of clinical neurophysiology, convey an automatic readiness to interpret MEGs, or is it irrelevant? Both of these opposing positions were endorsed by some survey participants. Nevertheless, it is clear to the more experienced clinical magnetoencephalographers that having an MD/DO and/or PhD degree, having pursued a residency in neurology, neurosurgery, or radiology, or even an Accreditation Council for Graduate Medical Education-approved fellowship is insufficient per se. Respondents were more declaratively united on the need for some kind of standardized training and an assurance of a certain amount of "experience" in analyzing and interpreting MEGs, than on the specifics. Most medical professionals would agree that five years in the field (after training) represents a significant experience (McCray et al., 2008) . However, in this survey, "experience" was purely chronologically based and varied widely, depending on the institution, with some busy magnetoencephalographers reading more clinical MEGs in an average month than some in the less busy laboratories see in five years (Bagi c, 2011) .
The survey demonstrated that both physicians and nonphysicians recognize the need for clinical MEG standards. Generally, 81% of the surveyed participants displayed a positive attitude by welcoming an "appropriate form of standardized training WITH certification" or believing that it "would improve the quality of patient care and help propel clinical MEG." One eighth of the respondents thought that clinical MEG standards already existed, and some even believed that "everybody in the field knows the standards." Yet either way, one out of five respondents still believed that "standards would not change what they do" (Bagi c, 2011) . It has been suggested that practitioners are far more likely to change their behavior if there is direct interaction between the subject matter experts and the practitioners (Akbari et al., 2008) . For clinical MEG, still very much a growing field, this presents a great opportunity.
So, the process of defining the first CPGs for MEG began. There are some initial philosophical questions that our group attempted to grapple with to create some context for our guidelines. These questions, and some brief summaries of our answers, are included below. The guidelines are not meant to be a comprehensive how-to manual for MEG. They are aimed at those already trained in MEG who are responsible for ensuring that their laboratory is conducting high-quality studies that are considered the standard of practice. The guidelines are meant to answer the specific questions that ensure some level of uniformity across laboratories. Just as with any other clinical test, reporting style differs from one MEG center to another. Physicians referring patients to MEG laboratories have sometimes found that the reports they receive back are impenetrable or do not answer the clinical question for which the patient was sent to the laboratory. Hence, there is a need to ensure that the test results are understandable and meet their expectations.
PHILOSOPHICAL QUESTIONS
2. Are these guidelines meant to be "minimal standards" or "best practices"? The ACMEGS was formed, in part, to advocate for best practices in MEG so that highquality clinical answers are delivered, and hence, MEG testing becomes even more valuable in clinical care. Therefore, even though the guidelines are not meant to establish a legal "standard of care," they are designed to point us in the direction of excellent standards of practicednot just minimal requirements. Not all laboratories are equipped the same, either in terms of their instrumentation or their operation, naturally, so not all laboratories can be expected to do things exactly the same way. We should assume that these initial guidelines are living documents that, with more maturity in the field, will eventually evolve into "best practices."
3. How detailed should the guidelines be? Guidelines developed at this stage of MEG must navigate a fine line between being so restrictive as to stifle innovations and improvements versus being so vague that they are simply impractical platitudes. However, there is no point in establishing guidelines that are too broad lest they leave new users with no guidance at all. While there are many laboratories that are quite comfortable and confident with their work product, others, especially those just starting up, are hungry for some relatively specific starting points. Hence, the level of detail included in these guidelines was meant to offer the minimal practical guidance desired by the MEG community. The specifically recommended settings may not cover every single clinical circumstance encountered, but they are meant to serve as excellent starting points, which have been verified in practice.
4. Shall we include only Center for Medical Services-approved clinical studies, or provide more general guidance that can be extrapolated to the conduct of research studies? These guidelines concentrate on the essential elements but do not dictate which services should be provided. Educational and research endeavors, by ACMEGS as well as by other organizations and universities, will provide the foundation for extending MEG studies into many realms of investigation. However, the guidelines focus on established areas where it is known that MEG works well. Magnetoencephalography's strength, and the primary reason for referral of patients to the MEG laboratory, is in localization. It is on the capability for localization that the guidelines focus, rather than on typical normal/abnormal decisions that depend on a normative database (as in traditional evoked potential studies). Although there are some promising applications for MEG that may someday become commonplace in clinical practice, these guidelines are meant to focus on the two established indications for MEG: localization of epileptic foci and presurgical functional brain mapping in patients with operable lesions.
5. What are the assumed technical standards for the equipment that we expect to be employed in this application? Do we need to specify, or leave to others? Because of the relatively high cost and comparative adolescence of magnetoencephalograph manufacturing, MEG recording systems are not commodities, and MEG analysis packages are not uniform. We chose to restrict ourselves to whole-head systems because these certainly are the standard for clinical use, but we expect that more advanced specifications, such as acceptable noise performance or adequate analog-to-digital converter resolution, will continue to evolve. Given the enormous capital costs of MEG apparatus, it is not reasonable to expect replacement or upgrade frequently.
INTENT AND PRACTICAL APPLICATION OF THE GUIDELINES
The main thrust of the CPGs development effort was to provide guidance that will help to improve the consistency and quality of the clinical application of MEG. The CPGs included in this journal are purposely not called "standards" but rather "guidelines." Guidelines are just that: they are meant to be helpful not dictatorial; they are meant as a starting point not a full prescription. Because these Guidelines are essentially a consensus starting point, there will be many laboratories, especially the better established ones, doing things slightly differently. The important thing is for laboratories to be aware that there are guidelines and to use them to make sure that they are at least living up to the basics of the Guidelines. It is by pushing the envelope outside of established practice that modern medicine innovates, either to improve accuracy and quality or to improve efficiency and cost. The Guidelines will probably be of most help to laboratories that do not know exactly what to do for each type of test and want to start from a known place.
It is not surprising in the translation of a basic research technology into a clinical diagnostic technique that the backgrounds and career orientations of those involved in MEG to date have been quite inhomogeneous. In this regard, the field of MEG today is quite similar to where the field of EEG was in the 1950s, because EEG and evoked potentials emerged from research laboratories into clinical practice. At that time, many of the world's experts were research scientists without medical training, as exemplified by the career of Peter Kellaway, PhD, to cite just one example (Mizrahi and Pedley, 2004) . The Guidelines recognize these differences and are meant to help pull the MEG community together for clinical purposes. Clinical Practice Guideline 4 (Bagi c et al., 2011) deserves special mention because some may view it as an attempt at de facto credentialing. While it is possible that credentialing of personnel and accreditation of laboratories will be considered in the future, the field is young and the contributions of a variety of neuroscientists are critical to continued nurturing of the field. It is anticipated that laboratories will reexamine their procedures as a result of these guidelines, but it is not expected that any individuals currently involved in the acquisition or processing of magnetoencephalograms will suddenly be excluded from these activities. On the contrary, this document points up the scarcity of good training programs in MEG and may help to bring together the ideas for a body of knowledge that should be part of the curricula in some fellowships or included in certain examinations. Clinical Practice Guideline 4 was built around the concept that these CPGs establish (1) best practices in 2011 where possible, (2) a need for and challenge to the MEG community to get training in place, and (3) a recognition of the important role of nonphysician MEG scientists and excellent technologists. Should there come a time when certification and/or laboratory accreditation is considered, there will doubtless be a period of grandfathering and other transitional measures required. At that time, an appropriate degree of sensitivity should be demonstrated toward experienced practitioners and their diverse routes to clinical practice, according to well-established approaches that have already been applied in other medical specialties.
